AKR1D1 and metabolic dysfunction-associated steatotic liver disease: Previous studies showed that the dysregulation of AKR1D1 might lead to non-alcoholic fatty liver disease (NAFLD) and NAFLD was the most common reason for chronic liver disease in Western countries [14, 15].